bioRxivBioengineering
Glioblastoma Margin as a Diffusion Barrier Revealed by Photoactivation of Plasmonic Nanovesicles
H. Xiong, B. A. Wilson, X. Ge, X. Gao, Q. Cai, X. Xu, R. Bachoo, Z. Qin
Abstract
Glioblastoma (GBM) is the most complex and lethal adult primary brain cancer. Adequate drug diffusion and penetration are essential for treating GBM, but how the spatial heterogeneity in GBM impacts drug diffusion and transport is poorly understood. Herein, we report a new method, photoactivation of plasmonic nanovesicles (PANO), to measure molecular diffusion in the extracellular space of GBM. By examining three genetically engineered GBM mouse models that recapitulate key clinical features including angiogenic core and diffuse infiltration, we found that the tumor margin has the lowest diffusion coefficient (highest tortuosity) compared with the tumor core and surrounding brain tissue. Analysis of the cellular composition shows that the tortuosity in the GBM is strongly correlated with neuronal loss and astrocyte activation. Our all-optical measurement reveals the heterogeneous GBM microenvironment and highlights the tumor margin as a diffusion barrier for drug transport in the brain, with implications for therapeutic delivery.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Optical Modulation of Blood-Brain-Tumor Barrier Permeability Enhances Drug Delivery in Diverse Preclinical Glioblastoma Models
- A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier penetrant nanoparticles
J. P. Straehla, C. Hajal, … P. T. Hammond·bioRxiv·Dec 7, 2021
- Modulation of blood-tumor barrier transcriptional programs improves intra-tumoral drug delivery and potentiates chemotherapy in GBM
Jorge L. Jimenez-Macias, Philippa C. Vaughn-Beaucaire, … Sean Edward Lawler·Science AdvancesPeer-reviewed·Feb 26, 2025
- Ultrasound-Triggered Chemotherapy Extends Survival in a Genetically Engineered Glioblastoma Model
Joshua Antonio Whiting, Audri Dara, … Jan Kubanek·bioRxiv·Jul 3, 2026
- PLGA-based dual-loaded nanoformulation of DIM and TMZ - An advanced clinical strategy for brain cancer treatment in a combinatorial approach
S. Sarkar, S. Kumar, … M. K. Ghosh·bioRxiv·May 4, 2023
- Targeting therapeutic nanoparticles to the glioblastoma resection margin by harnessing post-operative spatiotemporal blood-brain barrier disruption
Lorena F Fernandes, Chariya Peeyatu, … Thomas Kisby·bioRxiv·Mar 29, 2025